EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Efficacy of bismuth subsalicylate on the prevention of travellers′ diarrhoea, 2018–2023

Kristina M Angelo, Zainab Salah iD, Marina Rogova, Ian D Plumb iD, Allison T Walker, Graeme Prentice-Mott, Charandeep Waraich, Sunkyung Kim, Edward Ryan, Regina C LaRocque, Elizabeth Oliver, Kristen Heitzinger und 2 weitere

Journal of Travel Medicine · 2025

DOI: 10.1093/jtm/taaf047 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Travel Medicine, 2025. Verfasst von Kristina M Angelo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30329, USA. Hauptthemen laut MEDLINE: Diarrhea, Bismuth, Salicylates, Organometallic Compounds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, Cooperative Research and Development Agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Travellers’ diarrhoea (TD) is the most common travel-related illness. Bismuth subsalicylate (BSS) is indicated for the treatment of TD. BSS is also used off-label for the prevention of TD, based on studies from the 1980s indicating TD protection; however, these studies have limitations. The objective of this study was to determine the efficacy of BSS in the prevention of TD.

Methods

This study was a prospective, double-blinded, placebo-controlled, randomized clinical trial (NCT03535272) with two arms: BSS 4 tablets twice daily (2.1 grams of BSS total) vs placebo. Travellers were included if they were ≥ 18 and < 70 years of age at the time of enrollment, were leaving for an international trip ≥7 days after their pretravel consultation, travelling in country for ≥7 days but ≤ 21 days, and travelling to either Southeast Asia, South Central Asia, North Africa, or Sub-Saharan Africa. Self-completed web-based questionnaires were administered before, during, and after travel.

Results

270 participants were included. The median age was 32 years (Interquartile range [IQR]: 27–44); 63% were female. Travellers were most frequently White (144; 61%) and non-Hispanic (239; 94%). The most frequent country of travel was Kenya (n = 87; 32%). The median total trip duration was 10 days ([IQR]: 8–13). The most frequent reason for travel was leisure/tourism (230, 85%). There was no significant difference among the groups for symptoms of loose stool and/or diarrhoea, although target sample size was not reached.

Conclusions

This study provides the first new data since the 1980s about the potential use of BSS in the prevention of TD. These data should not be viewed as evidence in isolation because of sample size constraints; further studies are needed to determine if there is a benefit in certain traveller groups or under certain circumstances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiarrheaBismuthSalicylatesOrganometallic CompoundsTravelTravel-Related IllnessAntidiarrhealsHumansFemaleMaleAdultDouble-Blind MethodProspective StudiesMiddle AgedTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

Travellers’ diarrhoeapreventiontravel

Substanzen

bismuth subsalicylateBismuthSalicylatesOrganometallic CompoundsAntidiarrheals

Autor:innen und Institutionen

  • Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30329, USA.
  • New York Center for Travel and Tropical Medicine, 110 E 55th St, New York, NY 10022, USA.
  • Massachusetts General Hospital, Division of Infectious Diseases, 55 Fruit St, Boston, MA 02114, USA.
  • Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30329, USA.
  • Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA.

ORCID-Profile: Zainab Salah, Ian D Plumb

Förderung

  • Intramural CDC HHS
  • Cooperative Research and Development Agreement

Zitieren

APA

Angelo, K. M., Salah, Z., Rogova, M., Plumb, I. D., Walker, A. T., Prentice-Mott, G., Waraich, C., Kim, S., Ryan, E., LaRocque, R. C., Oliver, E., Heitzinger, K., Perry-Dow, K. A., & Connor, B. A. (2025). Efficacy of bismuth subsalicylate on the prevention of travellers′ diarrhoea, 2018–2023. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taaf047

Vancouver

Angelo KM, Salah Z, Rogova M, Plumb ID, Walker AT, Prentice-Mott G, et al. Efficacy of bismuth subsalicylate on the prevention of travellers′ diarrhoea, 2018–2023. Journal of Travel Medicine. 2025. doi:10.1093/jtm/taaf047

BibTeX
@article{Angelo2025,
  author = {Angelo, Kristina M and Salah, Zainab and Rogova, Marina and Plumb, Ian D and Walker, Allison T and Prentice-Mott, Graeme and Waraich, Charandeep and Kim, Sunkyung and Ryan, Edward and LaRocque, Regina C and Oliver, Elizabeth and Heitzinger, Kristen and Perry-Dow, K Allison and Connor, Bradley A},
  title = {Efficacy of bismuth subsalicylate on the prevention of travellers′ diarrhoea, 2018–2023},
  journal = {Journal of Travel Medicine},
  year = {2025},
  doi = {10.1093/jtm/taaf047}
}
Kostenlos starten →